advert
advert
Angel News

Back to Homepage

4th February 2019 - 0 comments

New campaign highlights diversity of tech startup community

Level39, one of Europe’s largest technology hubs, has launched a new campaign recognising the diversity and strength of its startup community. Building high-growth businesses in the face of political uncertainty, People Behind the Future celebrates diverse entrepreneurship in London. 

4th February 2019 - 0 comments

£1.25m loan helps advanced manufacturer prepare for growth

 

LSN Diffusion (LSN), a high-tech metallurgical business has secured a further £1.25m loan from the Development Bank of Wales to support their ambitious growth plans.  LSN’s cutting-edge technology is used to manufacture high alloy atomised powders used in high-tech industrial applications including 3D printing and specialised uses in the defence and other industrial sectors.

 

1st February 2019 - 0 comments

AI in Business: 2019 Trends and Predictions from Instant Office

AI is already being implemented in businesses around the world, and while worries persist over whether robots will be taking over the workplace, some are predicting that it will actually improve and even create jobs in the future.

From devices in our homes to mobile apps, AI has already made its way into our daily lives. The workplace is no exception and AI has already helped businesses make better use of data and streamline processes. According to John Williams, Head of Marketing at Instant Offices here are a few AI trends you should be aware of for your business:

1st February 2019 - 0 comments

VCT managers comment on Brexit

Uncertainty around Brexit has hit UK markets and raised questions about the UK’s economic prospects, but what effect is it having on the UK’s smaller unquoted companies? Despite a tough year, the average VCT returned 2.7% in 2018 and is up 42% and 163% over five and ten years. Where are VCT managers finding opportunities today and what are their views ahead of Brexit?

At a media roundtable held today by the Association of Investment Companies (AIC), John Glencross, CEO of Calculus Capital which manages the Calculus VCTIan McLennan, manager of the Triple Point VCTs, and Rodney Appiah, director of Foresight which manages the Foresight VCTs, discussed their recent investment activity, the potential effect of Brexit on smaller companies and their overall outlook for the sector.

1st February 2019 - 0 comments

One in four UK businesses expect double digit growth in 2019 says IGF

Over a quarter (27%) of business leaders are expecting revenues to grow by more than 10 percent in 2019, according to a new report by Independent Growth Finance (IGF), the leading independent asset based lender.  

Despite undeniable uncertainty in the economy, IGF’s Powering Freedom Report finds that British businesses turning over between £1 million and £500 million remain ‘bullish’ about the future. Nine in ten company leaders have concerns over Brexit yet they remain optimistic about opportunities in the year ahead. In fact seven in ten (69%) companies expect an increase in revenues.  

1st February 2019 - 0 comments

Ashish Life Science raises INR 45 crores in Series A funding

 

Ashish Life Science, an export focussed, veterinary pharmaceuticals company has raised INR 45 crores in Series A funding. Eight Roads Ventures India led the round with participation from Netherlands-based, food and agriculture-focussed specialist fund, Anterra Capital.  The Company will use this first round of external capital to scale the business in its current geographies and expand into regulated markets.

 

1st February 2019 - 0 comments

YFM 2018 in review and looking ahead to 2019

£30m invested; 5 exits; £600m of deals. What’s coming to UK small business in 2019?

For YFM 2018 was a year that confounded predictions.  We had predicted a year where Brexit and general uncertainty over slowing global growth might cloud events and perhaps dampen investment appetites.

1st February 2019 - 0 comments

UK medicinal marijuana startups take off says Beauhurst report

Last July, Oxford Cannabinoid Technologies raised $10m in equity finance. This was a significant moment in the UK’s investment scene, representing the first equity investment into a medicinal marijuana startup in nearly two decades (since GW Pharmaceuticals listed on the AIM in 2001).

Given the increasing noise about the potential of cannabis-derived drugs, and the increasingly soft stance of Home Secretary Sajid Javid, we predicted that this sector was on the tipping point of an investment “green rush”.

Our predictions have so far been borne out. Later in July Grow Biotech raised £2m in equity finance, at a £14m pre-money valuation. Under the helm of Ben Langley, an ex-Morgan Stanley trader, Grow Biotech is looking to bridge the gap between science and market in the medicinal marijuana sector. Essentially, they are looking to develop pharmaceutical IP, based on cannabis-derived compounds. Currently, they are in their R&D phase.

31st January 2019 - 0 comments

Don't miss the latest GrowthInvest Adviser Hour - out today

This 4th episode of Series 3 of The GrowthInvest Adviser Hour explores the wider drivers behind the growing popularity of “alternatives”, 

31st January 2019 - 0 comments

Milltrust highlights the potential of the UK’s university spinouts

Milltrust International, the award-winning investment group, has highlighted the commercial potential of spinout companies from the UK’s leading universities at its Science & Technology Day in London.

31st January 2019 - 0 comments

Key trends in UK Angel investment revealed

Angel Investment Network (AIN), the UK’s largest and first online angel investment network has revealed its first ‘State of the Angel Investment Nation’ findings. Based on the data of more than 100,000 businesses and 30,000 investors, it reveals a detailed picture of the angel investment landscape in the UK.  

31st January 2019 - 0 comments

Resonance gets £5m from Guy’s and St Thomas’ Charity to help tackle homelessness

The Resonance Real Lettings Property Fund² (RLPF²) has received a substantial investment from Guy’s and St Thomas’ Charity, the largest place-based health foundation in the UK, as part of its commitment to achieving positive health impact in the UK alongside investment return.

The Resonance Fund, managed by social impact investment company Resonance, was launched in 2015 and has now over £80m of funds under management following this investment. 

PREVIOUSItems 5304 of 7589NEXT

Back to Homepage